Oral Calcium in Pregnant Women With Hypertension
NCT00000543 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL
Last updated 2016-05-13
Summary
To determine of providing calcium supplementation to women with pre-existing hypertension reduces the level of blood pressure, requirement for antihypertensive drugs, and incidence of pre-eclampsia.
Conditions
- Cardiovascular Diseases
- Heart Diseases
- Hypertension
- Pre-Eclampsia
- Pregnancy Toxemias
- Vascular Diseases
Interventions
- BEHAVIORAL
-
dietary supplements
- DRUG
-
calcium
Sponsors & Collaborators
-
National Heart, Lung, and Blood Institute (NHLBI)
lead NIH
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- DOUBLE
Eligibility
- Min Age
- 18 Years
- Max Age
- 40 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1993-08-31
- Completion
- 1999-07-31
More Related Trials
-
Dietary Calcium Supplementation to Reduce Blood Lead in Pregnancy
NCT00558623 ·Status: COMPLETED ·Phase: NA
-
Hypertensive and Normal Pregnancy--Calcium Metabolism and Renin-Angiotensin - SCOR in Hypertension
NCT00005456 ·Status: COMPLETED
-
A Randomized Control Trial of Vitamin D Prophylaxis in the Prevention of Hypertensive Disorders of Pregnancy
NCT02920593 ·Status: UNKNOWN ·Phase: PHASE4
-
Combined Antioxidant and Preeclampsia Prediction Studies (CAPPS)
NCT00135707 ·Status: COMPLETED ·Phase: PHASE3
-
Prenatal Nutrient Status Study
NCT06156826 ·Status: COMPLETED
-
Vascular Inflammation and Anti-inflammatory Supplements After Adverse Pregnancy Outcomes
NCT04633551 ·Status: COMPLETED ·Phase: NA
-
Study of Nicotinamide in Early Onset Preeclampsia
NCT03419364 ·Status: COMPLETED ·Phase: PHASE2
-
L-Arginine and Antioxidant Vitamins During Pregnancy to Reduce Preeclampsia
NCT00469846 ·Status: TERMINATED ·Phase: PHASE2
-
Dietary Intervention Program for Pre-eclampsia in Women at Risk
NCT02706158 ·Status: UNKNOWN ·Phase: NA
-
Early Pregnancy Antioxidant Supplementation in the Prevention of Preeclampsia
NCT00583635 ·Status: COMPLETED
-
Prospects for the Prevention of Pregnancy-induced Hypertension and Preeclampsia Trial
NCT02007837 ·Status: UNKNOWN ·Phase: PHASE3
-
Vitamin D Status and Metabolism in Human Pregnancy
NCT03051867 ·Status: COMPLETED
-
L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE)
NCT05934318 ·Status: RECRUITING ·Phase: NA
-
Docosahexaenoic Acid Supplementation of Women With Hypertension in Pregnancy to Improve Endothelial Health
NCT02137408 ·Status: WITHDRAWN ·Phase: NA
-
Preventing Lack of Iodine During Pregnancy
NCT00379535 ·Status: TERMINATED ·Phase: PHASE3
-
Omega-3 Fatty Acid Supplementation to Prevent Preterm Birth in High Risk Pregnancies
NCT00135902 ·Status: COMPLETED ·Phase: PHASE3
-
Reducing the Risk of Chronic Hypertension and Improving Vascular Function Following Preeclampsia
NCT06220721 ·Status: RECRUITING ·Phase: NA
-
Vitamin D Treatment and Hypocalcemic Pregnant Women
NCT02021864 ·Status: UNKNOWN ·Phase: NA
-
Mobile Health Interventions to Prevent Heart Disease After Hypertensive Disorders of Pregnancy
NCT06523569 ·Status: RECRUITING ·Phase: NA
-
Phase I Study of Nicotinamide for Early Onset Preeclampsia
NCT02213094 ·Status: COMPLETED ·Phase: PHASE1
-
Angiotensinogen Variants and Adverse Pregnancy Outcomes
NCT00005400 ·Status: COMPLETED
-
Optimizing Cardiovascular Preventive Care for Women Following Hypertensive Disorders of Pregnancy
NCT05826925 ·Status: RECRUITING ·Phase: NA
-
Select Nutrient and Gene Variant Analysis in a Targeted Diet and Lifestyle Intervention Reduces Preterm Birth
NCT05436119 ·Status: UNKNOWN
-
Goal-Directed Therapy in Pregnant Women at High Risk of Developing Preeclampsia
NCT01351428 ·Status: COMPLETED ·Phase: NA
-
Angiotensin II and Chronic Inflammation in Persistent Microvascular Dysfunction Following Preeclampsia
NCT03482440 ·Status: COMPLETED ·Phase: EARLY_PHASE1